Nathaniel Myall

Professor contributing to global discussions on oncology and cancer research, Nathaniel Myall serves as a Clinical Assistant Professor of Medicine-Oncology at Stanford Medicine. With a specialized focus on Lung Cancer and Neuroendocrine Tumors, Dr. Myall is dedicated to advancing the understanding and treatment of these complex diseases. His commitment to patient care and medical excellence has been recognized through prestigious accolades, including the Humanism in Hematology/Oncology Award and the Charles Dorsey Armstrong Award for Excellence in Patient Care. Dr. Myall's academic journey is deeply rooted in Stanford University, where he completed his medical education at the Stanford University School of Medicine. He further honed his expertise through a residency in Internal Medicine, followed by a fellowship in Hematology and Oncology, both at Stanford University. His comprehensive training has equipped him with a robust foundation in the field, allowing him to contribute significantly to both clinical practice and research. Board-certified in Hematology, Oncology, and Internal Medicine by the American Board of Internal Medicine, Dr. Myall is committed to integrating cutting-edge research with compassionate patient care. His research interests are particularly centered on the molecular and clinical aspects of Neuroendocrine Tumors and Lung Cancer, aiming to develop innovative therapeutic strategies and improve patient outcomes. In addition to his clinical and research endeavors, Dr. Myall is actively involved in mentoring the next generation of medical professionals. He is passionate about fostering a collaborative learning environment that encourages critical thinking and innovation. His dedication to education is reflected in his involvement in various academic and professional development programs at Stanford Medicine. Dr. Myall's contributions extend beyond the academic and clinical settings, as he actively participates in national and international conferences, sharing his insights and findings with the broader medical community. His work continues to influence the field of oncology, driving forward the conversation on effective cancer treatments and patient-centered care.